Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue
This trial is active, not recruiting.
|Treatment||colposcopy, spectroscopy, and biopsy|
|Sponsor||University of New Mexico|
|Start date||April 2004|
|End date||December 2007|
|Trial size||100 participants|
|Trial identifier||NCT00250055, 1104C|
In general, to determine the sensitivity of light transport to tissue from morphological features of clinical significance.
Determine how specific structural features contribute to light scattering. Investigate light scattering differences in tumorigenic and nontumorigenic cells.
Develop and implement quantitative and sensitive methods for measuring morphological properties.
|Intervention model||single group assignment|
The objective of this study is to determine whether non-invasive measurements of light transport through tissue can identify pre-cancerous and cancerous conditions.
time frame: 6 years
Female participants at least 18 years old.
Inclusion Criteria: - Patients with abnormal Pap smears who are referred for colposcopy. Exclusion criteria include: - Anyone of the male sex since this study focuses on cervical cell abnormalities - Any woman who has had a hysterectomy, LEEP, or chemotherapy.
|Official title||Non-Invasive, Real-time Technology for Diagnosis of Cervical Tissue|
|Principal investigator||Harriet Smith, MD|
|Description||Patients undergoing a colposcopy will also have spectroscopy measurements taken and an extra biopsy of suspicious tissue.|
Call for more information